\begin{tabular}{lcccccc}
   \hline
 
         \multicolumn{1}{l}{Mock} & \multicolumn{1}{c}{No. cases /}   & \multicolumn{2}{c}{HR per 10-fold incr.}                     & \multicolumn{1}{c}{P-value}   & \multicolumn{1}{c}{q-value}   & \multicolumn{1}{c}{FWER} \\ 
         \multicolumn{1}{l}{Immunologic Marker}            & \multicolumn{1}{c}{No. at-risk**} & \multicolumn{1}{c}{Pt. Est.} & \multicolumn{1}{c}{95\% CI} & \multicolumn{1}{c}{(2-sided)} & \multicolumn{1}{c}{} & \multicolumn{1}{c}{} \\ 
         \hline
 
            
 \multicolumn{5}{l}{Day 57} \\ 
Anti Spike IgG (IU/ml) & 71/13,295 & 0.11 & (0.07-0.18) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  Anti RBD IgG (IU/ml) & 71/13,295 & 0.31 & (0.23-0.42) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  Pseudovirus-nAb ID50 & 71/13,295 & 0.36 & (0.27-0.50) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  Pseudovirus-nAb ID80 & 71/13,295 & 0.45 & (0.33-0.60) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
          
 \multicolumn{5}{l}{} \\ 
        
 \multicolumn{5}{l}{Fold-rise} \\ 
Anti Spike IgG (IU/ml) & 71/13,295 & 0.10 & (0.05-0.17) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  Anti RBD IgG (IU/ml) & 71/13,295 & 0.34 & (0.25-0.46) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  Pseudovirus-nAb ID50 & 71/13,295 & 0.48 & (0.36-0.64) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  Pseudovirus-nAb ID80 & 71/13,295 & 0.43 & (0.32-0.58) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
   \hline
\end{tabular}
